Ezabenlimab (BI-754091) is a humanized monoclonal antibody targeting programmed cell death protein-1 with antitumor activity that blocks the interaction of PD-1 with PD-L1 and PD-L2, inhibits tumor growth in vivo, and can be used to study advanced solid tumors.
Purity:
95.00%
CAS Number:
[2249882-54-8]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
